Moneycontrol
Get App
Last Updated : Oct 30, 2015 10:21 AM IST | Source: CNBC-TV18

Stocks in news: ICICI, Dr Reddy's, HCL Tech, Cipla, Nestle

ICICI Bank | ITC | Dr Reddy's Labs | Glenmark Pharma | Sonata Software | Polaris | HCL Technologies | SpiceJet | Blue Star | Cipla | Emami | Torrent Pharma | Jubilant Life | Grasim | Ador Welding | Crompton Greaves | Bharat Electronics | HCC | Nestle India | State Bank Of Travancore and IOC are stocks, which are in the news today.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Here are stocks that are in news today:


Results Today: ICICI Bank, ITC, Kotak Mahindra Bank, Larsen & Toubro, Titan Company, Suzlon Energy, Apollo Tyres, Century Textiles, Ajanta Pharma, IPCA Lab, Mahindra Lifespace, Karnataka Bank, Merck, Shoppers Stop, Religare Enterprises, Kalyani Steels, Jagran Prakashan, Gujarat Alkalies & Chemicals, Atul, 3M India, Century Enka, Elgi Equipments, EPC Industries, Gemini Communications, Jindal Drilling, Maharashtra Seamless, Munjal Showa, Nocil, Orient Paper, Sanghvi Forging, Smartlink Network, Subros, Srikalahasthi Pipes, TTML, Uttam Galva Steels, V-Mart Retail


Dr Reddy's Labs Q2
-Consolidated net profit at Rs 722 crore versus Rs 574.1 crore (YoY)
-Consolidated total income at Rs 3,989 crore versus Rs 3,587.8 crore (YoY)
-Consolidated operating profit at Rs 925.8 crore versus Rs 646.5 crore (YoY)
-Reported EBITDA margin at 28.6 percent versus 24.3 percent (YoY)
-North America revenue up 32 percent at Rs 1,860 crore (YoY)
-Global generics segment revenue up 15 percent at Rs 3,280 crore (YoY)
-Emerging markets revenue down 22 percent at Rs 660 crore (YoY)
-Russia revenue down 29 percent at Rs 290 crore (YoY)
-Rest Of World revenue down 24 percent at Rs 270 crore (YoY)
-India revenue up 14 percent at Rs 550 crore (YoY)
-Europe revenue up 65 percent at Rs 210 crore (YoY)
-Pharma services & active ingredients revenue down 7 percent at Rs 590 crore (YoY)
-Forex loss of Rs 35 crore versus forex gain of Rs 24.3 crore (YoY)
-Total number of DMF filings as on September 30 at 755

Close

Cigniti Technologies Q2
-Consolidated net profit up 18.7 percent at Rs 12.7 crore versus Rs 10.7 crore (QoQ)
-Consolidated total income up 12.1 percent at Rs 146.1 crore versus Rs 130.3 crore (QoQ)


State Bank Of Travancore Q2
-Net profit at Rs 102.8 crore versus Rs 19.2 crore (YoY)
-Gross NPAs at 3.82 percent versus 4.03 percent (QoQ)
-Net NPAs at 2.27 percent versus 2.47 percent (QoQ)
-Provisions at Rs 231.3 crore versus Rs 301.6 crore (QoQ); versus Rs 241.5 crore (YoY)
-Tax expense at Rs 39 crore versus Rs 13.9 crore (YoY)
-NII at Rs 645 crore versus Rs 582 crore (YoY)
-Gross NPAs at Rs 2,569.1 crore Rs 2,759.2 crore (QoQ)
-Net NPAs at Rs 1,498 crore versus Rs 1,653.9 crore (QoQ)


MRPL Q2
-Net loss at Rs 909.5 crore versus loss of Rs 951.5 crore (YoY)
-Total income down 35.8 percent at Rs 10,221 crore versus Rs 15,912 crore (YoY)


HCC Q2
-Net profit at Rs 38.4 crore versus Rs 6.8 crore (YoY)
-Total income at Rs 961.8 crore versus Rs 959 crore (YoY)
-HCC says current order book at Rs 16,988 crore excluding L1 contracts worth Rs 4,381 crore


Nestle India Q3
-Net profit at Rs 124.2 crore versus Rs 311.3 crore (YoY)
-Total income at Rs 1,742.4 crore versus Rs 2,570.4 crore (YoY)
-EBITDA at Rs 288 crore versus Rs 548 crore (YoY)
-EBITDA margin at 16.5 percent versus 21.3 percent (YoY)
-Exceptional item at Rs 24.5 crore


Nestle India says
-Q3 results impacted by Maggi noodles issue
-MD Suresh Narayanan has been given additional responsibility as chairman
-Have commenced manufacturing of Maggi noodles at 3 plants
-After clearance from labs, keen to re-introduce Maggi at the earliest
-Export sales decreased by 6.4 percent due to Maggi noodles issue
-Saw lower sales in Nepal due to blockage of border in September-end
-In talks to restart Maggi noodles production at Himachal & Uttarakhand units
-Sales of Rs 15.3 crore reversed in Q3 due to Maggi noodles stock being withdrawn


GIC Housing Q2
-Net profit at Rs 29.8 crore versus Rs 25.8 crore (YoY)
-Total income at Rs 215.6 crore versus Rs 178.7 crore (YoY)


Bharat Electronics (BEL) Q2
-Net profit at Rs 206.7 crore versus Rs 147 crore (YoY)
-Total income at Rs 1,467.7 crore versus Rs 1,294 crore (YoY)


Crompton Greaves Q2
-Consolidated net profit at Rs 52.1 crore versus Rs 69.6 crore (YoY)
-Consolidated total income at Rs 3,216.1 crore versus Rs 3,430.3 crore (YoY)


Essel Propack Q2
-Consolidated net profit at Rs 59.3 crore versus Rs 38.5 crore (YoY)
-Consolidated total income at Rs 535.3 crore versus Rs 595.1 crore (YoY)


Ador Welding Q2
-Net profit at Rs 3.4 crore versus Rs 20.3 crore (YoY)
-Total income at Rs 91.8 crore versus Rs 87.7 crore (YoY)
-Ador Welding appoints Girish Anant Patkar as CFO


RPG Life Q2
-Net profit at Rs 2.6 crore versus loss of Rs 7.4 crore (YoY)
-Total income at Rs 68.4 crore versus Rs 57.6 crore (YoY)


Grasim Q2
-Net profit up 13 percent at Rs 338.2 crore (YoY)
-Total income up 14.9 percent at Rs 1,838 crore (YoY)
-Operating profit up 32.6 percent at Rs 283.8 crore (YoY)
-Operating margin at 15.4 percent versus 13.4 percent (YoY)
-Effective tax rate at 13.9 percent versus 15.4 percent (YoY)
-VSF business revenue up 13 percent at Rs 1,436.8 crore (YoY)
-Chemicals business revenue up 26 percent at Rs 523 crore (YoY)


HeidelbergCement Q2
-Net profit at Rs 3.4 crore versus Rs 2.5 crore (YoY)
-Total income at Rs 402.7 crore versus Rs 406.1 crore (YoY)


Alstom T&D India Q2
-Net profit at Rs 46.3 crore versus Rs 35.6 crore (YoY)
-Total income at Rs 905.3 crore versus Rs 913.7 crore (YoY)


Jubilant Life Q2
-Consolidated net profit at Rs 115.8 crore versus loss of Rs 94.1 crore (YoY)
-Consolidated total income at Rs 1,463 crore versus Rs 1,371.1 crore (YoY)


Torrent Pharma Q2
-Consolidated net profit at Rs 568 crore versus Rs 198 crore (YoY)
-Consolidated total income at Rs 1,691 crore versus Rs 1,217 crore (YoY)


Emami Q2
-Consolidated net profit at Rs 61.3 crore versus Rs 91.5 crore (YoY)
-Consolidated total income at Rs 574.6 crore versus Rs 489.6 crore (YoY)
-Consolidated EBITDA at Rs 152 crore versus Rs 113 crore (YoY)
-Consolidated EBITDA margin at 26.5 percent versus 23.1 percent (YoY)


Praj Industries Q2
-Consolidated net profit at Rs 4.7 crore versus Rs 25 crore (YoY)
-Consolidated total income at Rs 203 crore versus Rs 265 crore (YoY)


Glenmark Pharma Q2
-Consolidated net profit at Rs 198 crore versus Rs 165 crore (YoY)
-Consolidated revenue at Rs 1,909 crore versus Rs 1,680.7 crore (YoY)
-Consolidated EBITDA at Rs 402 crore versus Rs 335.2 crore (YoY)
-Consolidated EBITDA margin at 21 percent versus 20 percent (YoY)
-India business up 27.3 percent at Rs 608.5 crore (YoY)
-US business up 17.9 percent at Rs 598.4 crore (YoY)
-Europe business up 22.8 percent at Rs 160.3 crore (YoY)
-Rest Of World business up 21.2 percent at Rs 211 crore (YoY)
Glenmark Pharma says
-Sanofi not to pursue development of Vatelizumab molecule further
-Company will continue to pursue relicensing of GBR 500 after its return from Sanofi


SKF India Q3
-Net profit down 14.7 percent at Rs 50 crore versus Rs 58.6 crore (YoY)
-Total income down 2.3 percent at Rs 598.7 crore versus Rs 612.8 crore (YoY)


IOC
-IOC to hike fuel supplies to Nepal: BS
-IOC, Delonex win oil block in Mozabique: PTI


Blue Star
-Enters into JV in MEP contracting business with WJ Towell, Oman
-Acquires 51 percent stake in JV entity, Blue Star Oman Electro-Mechanical Company LLC


SpiceJet says Sanjiv Kapoor resigns as COO w.e.f October 31
Sources say
-SpiceJet COO Sanjiv Kapoor likely to join Vistara Airlines
-Sanjiv Kapoor likely to join Vistara as chief commercial officer
-Sanjiv Kapoor may look at Vistara's network planning, revenue & sales management
-Vistara's present CCO Giam Ming Toh likely to step down
-Formal announcement on Sanjiv Kapoor joining Vistara may be made today

Other stocks and sectors that are in news today:
-Sonata Software to acquire IBIS for USD 14 million: BS
-Polaris gets board approval to hive off company's BPO business
-HCL Tech acquires CRM services provider PowerObjects
-Cipla to sell its entire 25 percent stake in Biomab Holding, Hong Kong for USD 25 million
-Glenmark Pharma gets tentative US FDA nod for epilepsy drug Lacosamide



Subscribe to Moneycontrol Pro and gain access to curated markets data, exclusive trading recommendations, independent equity analysis, actionable investment ideas, nuanced takes on macro, corporate and policy actions, practical insights from market gurus and much more.
First Published on Oct 30, 2015 08:20 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant